ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.750,71
-0,60%
S&P 500
5.300,83
1,03%
US Dollar vs BRL
5,1358
0,13%
Bitcoin
65.402,43
6,26%
Brent Oil
82,535
-0,02%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Obalon Therapeutics Inc (OBLN)

  7. Obalon Therapeutics Inc (OBLN) Notícias

OBLN

Obalon Therapeutics (OBLN)

Obalon Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OBLN
DataHoraFonteTítuloCódigoCompanhia
16/05/202307:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OBLNObalon Therapeutics Inc
15/05/202318:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OBLNObalon Therapeutics Inc
24/04/202310:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OBLNObalon Therapeutics Inc
03/04/202318:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:OBLNObalon Therapeutics Inc
17/03/202318:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:OBLNObalon Therapeutics Inc
14/02/202315:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OBLNObalon Therapeutics Inc
08/02/202311:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202311:02Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:OBLNObalon Therapeutics Inc
03/02/202308:05Edgar (US Regulatory)Withdrawal of a Registration Statement Withdrawal Request (rw Wd)NASDAQ:OBLNObalon Therapeutics Inc
12/01/202319:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:OBLNObalon Therapeutics Inc
20/12/202218:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OBLNObalon Therapeutics Inc
10/11/202218:56Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OBLNObalon Therapeutics Inc
31/10/202217:03Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OBLNObalon Therapeutics Inc
26/08/202217:22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OBLNObalon Therapeutics Inc
16/08/202207:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:OBLNObalon Therapeutics Inc
22/03/202207:04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OBLNObalon Therapeutics Inc
21/09/202117:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:OBLNObalon Therapeutics Inc
03/09/202117:07Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OBLNObalon Therapeutics Inc
21/05/202110:00Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OBLNObalon Therapeutics Inc
12/05/202109:40GlobeNewswire Inc.Obalon Announces First Quarter 2021 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
09/04/202118:22Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:OBLNObalon Therapeutics Inc
30/03/202107:11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:OBLNObalon Therapeutics Inc
15/03/202111:51Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OBLNObalon Therapeutics Inc
12/03/202121:12GlobeNewswire Inc.Obalon Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
03/02/202119:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OBLNObalon Therapeutics Inc
06/11/202018:45GlobeNewswire Inc.Obalon Announces Third Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
25/09/202017:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OBLNObalon Therapeutics Inc
01/09/202017:55Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OBLNObalon Therapeutics Inc
13/08/202008:00GlobeNewswire Inc.Obalon Announces Consulting Agreement As Part of Strategy To Seek Coverage and Reimbursement for The Obalon Balloon SystemNASDAQ:OBLNObalon Therapeutics Inc
30/07/202007:38GlobeNewswire Inc.Obalon Announces Second Quarter 2020 Financial ResultsNASDAQ:OBLNObalon Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OBLN

Seu Histórico Recente

KUCN
MATICBTC
Polygon
TSX
OREA
Orea Mining
NASDAQ
BEXP
NYSE
XKC
Lehman Abs Corning
BIT
NMMAO
New Millennium Multi Ass...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados